# Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer

Source: https://onco.cc/trials/nct07636798/  
OnCo record `nct07636798` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of envafolimab and lenvatinib in gallbladder cancer and other biliary tract cancers, run by West China Hospital, now recruiting.

## Summary

Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer is a phase 1/2 interventional study registered as NCT07636798 by West China Hospital, with a registry enrolment figure of 20 participants, started 2026-06 and due to reach its primary completion in 2029-03. Interventions recorded: HAIC Combined Regimen Treatment Group. Conditions listed: Biliary Tract Cancer. Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; gallbladder-deep-dive
- Registry id: NCT07636798
- Phase: 1/2
- Setting: Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy (GP Regimen) and Intra-arterial Infusion of Envafolimab Combined With Lenvatinib for Unresectable Advanced First-line Biliary Tract Cancer: A Multicenter, Phase Ib/II, Single-arm Clinical Study
- Sponsor: West China Hospital
- Enrolled: 20

## Sources

- ClinicalTrials.gov NCT07636798: https://clinicaltrials.gov/study/NCT07636798

## Connected records

- cancers: [Biliary tract cancer (all types)](https://onco.cc/cancers/biliary-tract-cancer/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/), [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- drugs: [Envafolimab](https://onco.cc/drugs/envafolimab/), [Lenvatinib](https://onco.cc/drugs/lenvatinib/)
- terms: [Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)](https://onco.cc/terms/gallbladder-cancer-in-biliary-trials/)

---
JSON: https://onco.cc/api/v1/entities/nct07636798.json